Nippon Life Global Investors Americas, Inc. Dexcom Inc Transaction History

Nippon Life Global Investors Americas, Inc.

$2.3 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $2.04 Million - $2.5 Million	17,840 Added 61.82%	46,700 $6.48 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $2.48 Million - $3.98 Million	28,860 New	28,860 $2.69 Million
Q2 2022 Aug 02, 2022	SELL	$67.99 - $132.89 $1.33 Million - $2.6 Million	-19,530 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$94.08 - $130.2 $677,376 - $937,439	7,200 Added 58.39%	19,530 $9.99 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $1.6 Million - $2.01 Million	12,330 New	12,330 $6.62 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.

Account